Is pseudo-intractability in population of patients with epilepsy still alive in 21 century? Audit of 100 seizure free patients, referred with the diagnosis of pharmacoresistant epilepsy

Neuroendocrinology Letters

Volumn 31, Issue 6, 2010, Pages 818-822

  Bajaček, Michal ^a   Hovorka, Jiří ^a   Nežádal, Tomáš ^a   Němcová, Iveta ^a   Herman, Erik ^a  

^a Nemocnice Na Franti ku   (Czech Republic)

Author keywords

Focal epilepsy; Idiopathic generalized epilepsy; Pharmacoresistant epilepsy; Pseudo intractable epilepsy; Psychogenic non epileptic seizures; Video EEG

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID;

ADULT; AGED; ANTICONVULSANT THERAPY; ARTICLE; DIAGNOSTIC ERROR; DISEASE CLASSIFICATION; DISEASE FREE INTERVAL; DRUG DOSE REGIMEN; DRUG TREATMENT FAILURE; ELECTROENCEPHALOGRAM; EPILEPSY; FEMALE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HUMAN; IDIOPATHIC DISEASE; INTRACTABLE EPILEPSY; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; NOMENCLATURE; PATIENT COMPLIANCE; PRESCRIPTION; PSEUDOINTRACTABLE EPILEPSY; RETROSPECTIVE STUDY; SEIZURE SUSCEPTIBILITY; THERAPEUTIC ERROR; THERAPY RESISTANCE;

EID: 77956641666     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Benbadis SR, Hauser WA (2000). An estimate of the prevalence of psychogenic non-epileptic seizures. Seizure. 9: 280-1. (Pubitemid 30427138)
2. Benbadis S R, O'Neill E, Tatum W O, Heriaud L (2004). Outcome of Prolonged Video-EEG Monitoring at a Typical Referral Epilepsy Center. Epilepsia. 45(9): 1150-1153. (Pubitemid 39238127)
3. Benbadis S R (2005). Practical Management Issues for Idiopathic Generalized Epilepsies. Epilepsia. 46(Suppl. 9): 125-132.
4. Besag FMC, Berry DJ, Pool F, Newbery JE, Subel B (1998). Carbamazepine toxicity with lamotrigine: pharmacokinetic or pharmacodynamic interaction. Epilepsia. 39: 183-7.
5. Brodie MJ, Kwan P (2002). Staged approach to epilepsy management. Neurology. 58 (8 Suppl 5): 2-8.
6. Chapman K, Wyllie E, Najm I, Ruggieri P, Bingaman W, Luders J, Kotagal P, Lachhwani D., Dinner D, Luders H O (2005). Seizure outcome after epilepsy surgery in patients with normal preoperative MRI. Journal of Neurology, Neurosurgery, and Psychiatry. 76: 710-713. (Pubitemid 40569684)
7. Cramer JA, Mattson RH, Prevey ML, et al (1989). How often is medication taken as prescribed? A novel assessment technique. JAMA. 261: 3273-3277. (Pubitemid 19143549)
8. Cramer JA, Glassman M, Rienzi V (2002). The relationship between poor medication compliance and seizures. Epilepsy Behav. 3: 338-342. (Pubitemid 35256232)
9. Cramer JA (2003). Obtaining optimal compliance with drug therapy. Manag Care. 12(10 suppl): 9-11.
10. Forsgren L, Beghi ., Öun A and Sillanpää M (2005). The epidemiology of epilepsy in Europe - a systematic review. European Journal of Neurology. 12(4): 245-253. (Pubitemid 40477131)
11. Hadač J, Marusič P (2004). Indikace k epileptochirurgické léčbě in Brázdil M, Hadač J, Marusič P a kol. Farmakorezistentní epilepsie. 8: 177-181.
12. Hovorka H, Nežádal T, Herman E, Němcová I, Bajaček M (2007). Psychogenic non-epileptic seizures, prospective clinical experience: diagnosis, clinical features, risk factors, psychiatric comorbidity, treatment outcome Epileptic Disorders. Epileptology in Czech Republic. 9(5-Supplement no1): 52-8.
13. Hovorka J (2009). Epilepsy pharmacotherapy according to clinical guidelines? Neurol. pro praxi. 10(4): 228-236.
14. Komárek V, Hovorka J (2004). Psedofarmakorezistence a zásady racionální farmakoterapie in Brázdil M, Hadač J, Marusič P a kol. Farmakorezistentní epilepsie. 7: 171-175.
15. Kwan P, Brodie M (2000). Early identification of refractory epilepsy. N Engl J Med. 342: 314-9. (Pubitemid 30075244)
16. Nakken KO, Solaas MH, Kjeldsen MJ, Friis ML, Pellock JM and Corey LA (2005). Which seizure-precipitating factors do patients with epilepsy most frequently report, Epilepsy & Behavior. 6: 85-89.
17. Perucca E (2002). Overtreatment in epilepsy: adverse consequences and mechanisms Epilepsy Research. 52: 25-33.
18. Perucca E (2006). Clinically relevant drug interactions with antiepileptic drugs, Br J Clin Pharmacol. 61(3): 246-255.
19. Sabers A, Ohman I, Christensen J, Tomson T (2003). Oral contraceptives reduce lamotrigine plasma levels. Neurology. 61: 570-571. (Pubitemid 37025386)
20. Schachter SC, Schomer DL (1997). The comprehensive evaluation and treatment of epilepsy. San Diego, CA: Academic Press; 61-74.
21. Tan JH, Einar WS, Erle CH. and Ong B (2005). Frequency of provocative factors in epileptic patients admitted for seizures: A prospective study in Singapore Siezure. 14: 464-469.
22. Thomas P, Valton L, Genton P (2006). Do carbamazepine and Phenytoine aggravate juvenile myoclonic epilepsy. Brain. 129: 1281-92.
23. Viteva EI, Zahariev ZI (2009). Pseudoresistance in patients with epilepsy - characteristics and determining factors. Folia Med (Plovdiv). 51(2):33-9.